Team Elysium, a Korea-based developer of digital musculoskeletal diagnostic and treatment solutions, has successfully completed its pre-SeriesA funding round.

This round included participation from existing investors Strong Ventures and Digital Healthcare Partners(DHP), along with new investors Evergreen Investment Partners and JIRAN PARTNERS.

Team Elysium plans to accelerate the expansion of its business model, which targets not only medical institutions but also non-medical entities such as fitness centers and corporations. This strategy aims to grow its revenue stream from musculoskeletal diagnostic solutions.

The company is dedicated to continuously developing innovative musculoskeletal analysis technologies, replacing traditional tools in clinical settings. This initiative has led to more than 300 medical institutions adopting Team Elysium’s products.

Moreover, Team Elysium has been making significant strides in the B2G sector. Following the launch of a program last year to manage physical imbalances in teenagers, it has since provided diagnostic tests and customized management programs for body imbalances to all fourth-grade students in the Jeollabuk-do region.

An Daegun, CEO of JIRAN PARTNERS, a participant in the additional multi-closing, remarked, “We have recognized the high growth potential in Team Elysium’s business expansion strategy, underpinned by its unique technological capabilities. With this investment, JIRAN PARTNERS is committed to actively supporting Team Elysium in becoming a leading company in both the domestic and international digital musculoskeletal diagnostic and treatment markets.”

Wonjin Kim, CEO of Team Elysium, stated, “Our persistent efforts to address the real-world challenges associated with musculoskeletal disorders are yielding results, as evidenced by our consistent sales growth. This pre-Series A funding will enable us not only to dominate the domestic musculoskeletal market but also to enhance our competitiveness in global markets.”